The Value of Advanced MR Imaging in Gynecological Tumors and Benign Uterine Fibroids

Gynecologic Tumor Clinical Trial

Official title: The Value of Advanced MR Imaging in Gynecological Tumors and Benign Uterine Fibroids

Status Terminated

Clinical Trial Summary

This research is being done to test new MRI methods called Magnetic Resonance Fingerprinting and Q-space Trajectory Imaging in gynecological abnormalities. The purpose of this research study is to evaluate if these new MRI methods can give additional information in characterizing gynecological tumors compared with conventional MRI.

Clinical Trial Description

Magnetic resonance imaging (MRI) is a safe and painless test that uses a magnetic field and radio waves to produce detailed images of the body's organs and structures. This research is being done to test new MRI methods called Magnetic Resonance Fingerprinting (MRF) and Q-space Trajectory Imaging (QTI) in gynecological abnormalities. The purpose of this research study is to evaluate if these new MRI methods can give additional information in characterizing gynecological tumors compared with conventional MRI In this research study, the investigators are: - Investigating the use of MR imaging in gynecological tumors on imaging quality and comparison of tumor or fibroid structures and normal anatomy - Investigating whether new MRI methods could help in characterizing the tumor and give information about the expected outcome ;

Related Conditions & MeSH terms

• Genital Neoplasms, Female
• Gynecologic Tumor
• Leiomyoma

• NCT number: NCT03993210
• Study type: Interventional
• Source: Dana-Farber Cancer Institute
• Status: Terminated
• Phase: N/A
• Start date: September 18, 2019
• Completion date: September 19, 2019